Global and United States Hidradenitis Suppurativa Treatment Market Report & Forecast 2022-2028

Hidradenitis suppurativa (HS) is a painful, long-term skin condition that causes abscesses and scarring on the skin.
The exact cause of hidradenitis suppurativa is unknown, but it occurs near hair follicles where there are sweat glands, usually around the groin, bottom, breasts and armpits.
There's no cure for HS, but treatments and lifestyle changes can bring some relief and cut down on flare-ups.
Market Analysis and Insights: Global and United States Hidradenitis Suppurativa Treatment Market
This report focuses on global and United States Hidradenitis Suppurativa Treatment market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Hidradenitis Suppurativa Treatment market size is estimated to be worth US$ 672.6 million in 2022 and is forecast to a readjusted size of US$ 860.9 million by 2028 with a CAGR of 4.2% during the review period. Fully considering the economic change by this health crisis, by Type, Medications accounting for % of the Hidradenitis Suppurativa Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospitals was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
The classification of Hidradenitis Suppurativa Treatment includes Medications, Surgery and others, and the proportion of Medications in 2019 is about 76%.
Hidradenitis Suppurativa Treatment is widely used in Hospital, Clinical and other field. The most proportion of Hidradenitis Suppurativa Treatment is Hospital, and the proportion in 2019 is 53.53%.
Europe is the largest consumption place with a consumption market share of 47.76% in 2019. Following Europe, Asia Pacific is the second largest consumption place with the consumption market share of 23.97%.
Market competition is intense. AbbVie, Merck, Pfizer, AstraZeneca, GlaxoSmithKline, etc. are the leaders of the industry.
Global Hidradenitis Suppurativa Treatment Scope and Market Size
Hidradenitis Suppurativa Treatment market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Hidradenitis Suppurativa Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Hidradenitis Suppurativa Treatment market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Medications
Surgery
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
AbbVie
Merck
Pfizer
AstraZeneca
GlaxoSmithKline
Perrigo
Sun Pharma
Almirall
Bausch Health
Johnson & Johnson